Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by okgonowon Oct 02, 2023 1:19pm
88 Views
Post# 35665283

RE:RE:IDK

RE:RE:IDK
subaru1i wrote: I'll pay $1.5 million of Good Will value relative to having a good business relationship with Tilray going forward.  Rescheduling by DEA will lift all cannabis stocks including Tilray's stock price....a good investment to have some Tilray stock.   Also, what happens when the price of flower and biomass for extraction goes up in price when DEA reschedules and/or U.S. Fed legalizes recreational.   That good business relationship could pay off 10 fold with Tilray if in the future the former VIVO growing capacity is not enough for LABS and LABS can leverage, with their hybrid strains, growing capacity from Tilray.  

There's a lot of moving parts not only in the snapshot you presented today but over the next 12 months as well.   

Not picking at your post, just providing a little different view.   

The other Good Will is that investors in LABS now no longer have to worry of how that whole mess will get settled.  It's now history and a future to look at bigger things going forward.  




i made no judgement one way or the other i just presented the facts of the deal and said IDK if its a good or bad deal. thats why i put it out there for some discussion.

as for price increase of the biomass they have $500k on account with Tillray (i dont know much about their buissness, do they grow their own pot? ) so if price of Biomass goes up the $500k buying power will go down acordingly. again i hope it's $500k of wholesale buying power but still will go down with price increase
<< Previous
Bullboard Posts
Next >>